116 related articles for article (PubMed ID: 7249281)
1. Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.
Townsend ER; Duffin J; Ali M; McDonald JW; Thiesson JJ; Masterson J; Klement P; Cooper JD
Circ Res; 1981 Aug; 49(2):452-7. PubMed ID: 7249281
[TBL] [Abstract][Full Text] [Related]
2. The effect of sulfinpyrazone on platelet and pulmonary responses to onset of membrane oxygenator perfusion.
Birek A; Duffin J; Glynn MF; Cooper JD
Trans Am Soc Artif Intern Organs; 1976; 22():94-101. PubMed ID: 951897
[No Abstract] [Full Text] [Related]
3. Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
Cerskus AL; Ali M; McDonald JW
Thromb Res; 1980 Jun; 18(5):693-705. PubMed ID: 7414555
[No Abstract] [Full Text] [Related]
4. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin production associated with the pulmonary vascular response to complement activation.
Cooper JD; McDonald JW; Ali M; Menkes E; Masterson J; Klement P
Surgery; 1980 Aug; 88(2):215-21. PubMed ID: 7394704
[No Abstract] [Full Text] [Related]
6. Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.
McDonald JW; Ali M; Morgan E; Townsend ER; Cooper JD
Circ Res; 1983 Jan; 52(1):1-6. PubMed ID: 6687354
[TBL] [Abstract][Full Text] [Related]
7. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.
Domoto DT; Bauman JE; Joist JH
Thromb Res; 1991 Jun; 62(6):737-43. PubMed ID: 1926064
[TBL] [Abstract][Full Text] [Related]
8. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Lorenz R; Siess W; Weber PC
Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
[TBL] [Abstract][Full Text] [Related]
9. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
10. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats.
Dejana E; Barbieri B; Cerletti C; Livio M; de Gaetano G
Br J Haematol; 1980 Nov; 46(3):465-9. PubMed ID: 7448129
[TBL] [Abstract][Full Text] [Related]
11. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
[TBL] [Abstract][Full Text] [Related]
12. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Baumgartner HR
Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Pedersen AK; FitzGerald GA
Clin Pharmacol Ther; 1985 Jan; 37(1):36-42. PubMed ID: 3917387
[TBL] [Abstract][Full Text] [Related]
14. Low-dose aspirin in pregnancy.
Sibai BM; Mirro R; Chesney CM; Leffler C
Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
[TBL] [Abstract][Full Text] [Related]
15. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
Ali M; McDonald JW
Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits.
Fountain SW; Martin BA; Musclow CE; Cooper JD
Circ Res; 1980 Feb; 46(2):175-80. PubMed ID: 7351034
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of platelet cyclooxygenase inhibition.
Patrono C; Ciabattoni G; Patrignani P; Pugliese F; Filabozzi P; Catella F; Davì G; Forni L
Circulation; 1985 Dec; 72(6):1177-84. PubMed ID: 3933848
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
McDonald JW; Stuart RK; Barnett HJ
Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
[No Abstract] [Full Text] [Related]
19. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo.
Huijgens PC; van den Berg CA; Imandt LM; Miltenburg A; Langenhuijsen MM
Scand J Haematol; 1986 Jan; 36(1):92-5. PubMed ID: 3081996
[TBL] [Abstract][Full Text] [Related]
20. Blood conservation with membrane oxygenators and dipyridamole.
Teoh KH; Christakis GT; Weisel RD; Madonik MM; Ivanov J; Wong PY; Mee AV; Levitt D; Benak A; Reilly P
Ann Thorac Surg; 1987 Jul; 44(1):40-7. PubMed ID: 3300583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
